Atlas Trials

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Clinical trial NCT06204302 · COMPLETED

Trial details

NCT number
NCT06204302
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Start date
2024-01-05
Primary completion
2024-04-04
Enrollment
1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.